124 related articles for article (PubMed ID: 28818538)
1. Impact of Positron Emission Tomography and Endoscopic Ultrasound Length of Disease Difference on Treatment Planning in Patients with Oesophageal Cancer.
Foley KG; Morgan C; Roberts SA; Crosby T
Clin Oncol (R Coll Radiol); 2017 Nov; 29(11):760-766. PubMed ID: 28818538
[TBL] [Abstract][Full Text] [Related]
2. Additional value of EUS in oesophageal cancer patients staged N0 on PET/CT: validation of a prognostic model.
Foley KG; Fielding P; Lewis WG; Roberts SA
Surg Endosc; 2018 Dec; 32(12):4973-4979. PubMed ID: 29869086
[TBL] [Abstract][Full Text] [Related]
3. Prospective comparison of MR with diffusion-weighted imaging, endoscopic ultrasound, MDCT and positron emission tomography-CT in the pre-operative staging of oesophageal cancer: results from a pilot study.
Giganti F; Ambrosi A; Petrone MC; Canevari C; Chiari D; Salerno A; Arcidiacono PG; Nicoletti R; Albarello L; Mazza E; Gallivanone F; Gianolli L; Orsenigo E; Esposito A; Staudacher C; Del Maschio A; De Cobelli F
Br J Radiol; 2016 Dec; 89(1068):20160087. PubMed ID: 27767330
[TBL] [Abstract][Full Text] [Related]
4. Metabolic tumor volume provides complementary prognostic information to EUS staging in esophageal and junctional cancer.
Malik V; Johnston C; O'Toole D; Lucey J; O'Farrell N; Claxton Z; Reynolds JV
Dis Esophagus; 2017 Feb; 30(3):1-8. PubMed ID: 27862622
[TBL] [Abstract][Full Text] [Related]
5. Radiological prediction of positive circumferential resection margin in oesophageal cancer.
Foley KG; Christian A; Patel N; Lewis WG; Roberts SA
Eur J Radiol; 2018 Oct; 107():119-124. PubMed ID: 30292255
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of 18-FDG PET/CT and EUS-defined tumour characteristics in patients with oesophageal cancer.
Chan DS; Fielding P; Roberts SA; Reid TD; Ellis-Owen R; Lewis WG
Clin Radiol; 2013 Apr; 68(4):352-7. PubMed ID: 22981727
[TBL] [Abstract][Full Text] [Related]
7. Impact of Endoscopic Ultrasonography on
Hulshoff JB; Mul VEM; de Boer HEM; Noordzij W; Korteweg T; van Dullemen HM; Nagengast WB; Oppedijk V; Pierie JPEN; Plukker JTM
Ann Surg Oncol; 2017 Jul; 24(7):1828-1834. PubMed ID: 28303427
[TBL] [Abstract][Full Text] [Related]
8. The Prognostic Role of Pre-operative Positron Emission Tomography-Computed Tomography and Endoscopic Ultrasound Parameters in Oesophageal Adenocarcinoma.
Dellaportas D; Zylstra J; Gossage J; Baker C; Kelly M; Hemelrijck MV; Griffin N; Lagergren J; Davies AR
Chirurgia (Bucur); 2019; 114(4):443-450. PubMed ID: 31511130
[No Abstract] [Full Text] [Related]
9. N-staging of oesophageal and junctional carcinoma: is there still a role for EUS in patients staged N0 at PET/CT?
Foley KG; Lewis WG; Fielding P; Karran A; Chan D; Blake P; Roberts SA
Clin Radiol; 2014 Sep; 69(9):959-64. PubMed ID: 24916652
[TBL] [Abstract][Full Text] [Related]
10. Pragmatic staging of oesophageal cancer using decision theory involving selective endoscopic ultrasonography, PET and laparoscopy.
Findlay JM; Bradley KM; Maile EJ; Braden B; Maw J; Phillips-Hughes J; Gillies RS; Maynard ND; Middleton MR
Br J Surg; 2015 Nov; 102(12):1488-99. PubMed ID: 26458070
[TBL] [Abstract][Full Text] [Related]
11. A comparative study of quantitative assessment with fluorine-18-fluorodeoxyglucose positron-emission tomography and endoscopic ultrasound in oesophageal cancer.
Borakati A; Razack A; Cawthorne C; Roy R; Usmani S; Ahmed N
Nucl Med Commun; 2018 Jul; 39(7):628-635. PubMed ID: 29672466
[TBL] [Abstract][Full Text] [Related]
12. Accuracy of contemporary oesophageal cancer lymph node staging with radiological-pathological correlation.
Foley KG; Christian A; Fielding P; Lewis WG; Roberts SA
Clin Radiol; 2017 Aug; 72(8):693.e1-693.e7. PubMed ID: 28363659
[TBL] [Abstract][Full Text] [Related]
13. Is positron emission tomography useful in locoregional staging of esophageal cancer? Results of a multidisciplinary initiative comparing CT, positron emission tomography, and EUS.
Sandha GS; Severin D; Postema E; McEwan A; Stewart K
Gastrointest Endosc; 2008 Mar; 67(3):402-9. PubMed ID: 18178202
[TBL] [Abstract][Full Text] [Related]
14. Comparative study between endoscopic ultrasonography and positron emission tomography-computed tomography in staging patients with esophageal squamous cell carcinoma.
Yen TJ; Chung CS; Wu YW; Yen RF; Cheng MF; Lee JM; Hsu CH; Chang YL; Wang HP
Dis Esophagus; 2012 Jan; 25(1):40-7. PubMed ID: 21595776
[TBL] [Abstract][Full Text] [Related]
15. Concordance of studies for nodal staging is prognostic for worse survival in esophageal cancer.
Dhupar R; Correa AM; Ajani J; Betancourt S; Mehran RJ; Swisher SG; Hofstetter WL
Dis Esophagus; 2014; 27(8):770-6. PubMed ID: 24152134
[TBL] [Abstract][Full Text] [Related]
16. Multiple staging investigations may not change management in patients with high-grade dysplasia or early esophageal adenocarcinoma.
Reyhani A; Gimson E; Baker C; Kelly M; Maisey N; Meenan J; Subesinghe M; Hill M; Lagergren J; Gossage J; Zeki S; Dunn J; Davies A
Dis Esophagus; 2023 Sep; 36(10):. PubMed ID: 37032121
[TBL] [Abstract][Full Text] [Related]
17. Endoscopic ultrasound staging for early esophageal cancer: Are we denying patients neoadjuvant chemo-radiation?
Luu C; Amaral M; Klapman J; Harris C; Almhanna K; Hoffe S; Frakes J; Pimiento JM; Fontaine JP
World J Gastroenterol; 2017 Dec; 23(46):8193-8199. PubMed ID: 29290655
[TBL] [Abstract][Full Text] [Related]
18. Endoscopic ultrasonography in esophageal cancer leads to improved survival rates: results from a population-based study.
Wani S; Das A; Rastogi A; Drahos J; Ricker W; Parsons R; Bansal A; Yen R; Hosford L; Jankowski M; Sharma P; Cook MB
Cancer; 2015 Jan; 121(2):194-201. PubMed ID: 25236485
[TBL] [Abstract][Full Text] [Related]
19. Discordant nodal staging identifies intermediate-risk group for overall survival in patients with cT3 oesophageal adenocarcinoma.
Carder C; Fielding P; Roberts A; Foley K
Eur Radiol; 2020 Jun; 30(6):3429-3437. PubMed ID: 32055952
[TBL] [Abstract][Full Text] [Related]
20. Endoscopic ultrasound in esophageal carcinoma: comparison with multislice computed tomography and importance in the clinical decision making process.
Moorjani N; Junemann-Ramirez M; Judd O; Fox B; Rahamim JS
Minerva Chir; 2007 Aug; 62(4):217-23. PubMed ID: 17641581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
